Amgen Inc.
AMGNSell · Weight Down
ARK net-sold the stock and the price fell, decreasing its portfolio weight.
Shares -99.8% · Market value -99.8% · Weight -0.12%p
| Date | Action | ETF | Shares | Close | Est. total |
|---|---|---|---|---|---|
| 26.03.05 | SELL | ARKG | 101 | $367.60 | $37.1K |
| 26.03.04 | SELL | ARKG | 1,254 | $379.27 | $475.6K |
| 26.03.03 | SELL | ARKG | 38,698 | $377.00 | $14.6M |
| 26.02.25 | SELL | ARKG | 3,172 | $384.33 | $1.2M |
| 25.11.18 | SELL | ARKG | 956 | $343.99 | $328.9K |
| 25.11.13 | SELL | ARKG | 1,682 | $336.00 | $565.2K |
| 25.08.06 | SELL | ARKG | 8,472 | $284.67 | $2.4M |
| 25.04.23 | BUY | ARKG | 1,318 | $277.90 | $366.3K |
| 25.04.22 | BUY | ARKG | 537 | $278.40 | $149.5K |
| 25.04.21 | BUY | ARKG | 2,161 | $273.68 | $591.4K |
| 25.03.21 | SELL | ARKG | 990 | $316.04 | $312.9K |
| 25.03.20 | SELL | ARKG | 602 | $315.04 | $189.7K |
| 25.03.19 | SELL | ARKG | 1,502 | $315.75 | $474.3K |
| 25.03.17 | SELL | ARKG | 6,807 | $317.17 | $2.2M |
| 24.07.15 | BUY | ARKG | 5,374 | $330.15 | $1.8M |
Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
Analyst Consensus
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Price Information
Trading Volume
Valuation
Financials
Profitability
Dividend
Technical
Amgen Inc. is a global biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. Its main products include treatments for conditions like rheumatoid arthritis, osteoporosis, multiple myeloma, and thyroid eye disease, among others. Amgen is a leading player in the biopharmaceutical industry, serving healthcare providers worldwide.
AI-generated summary. Not investment advice.
Related ARK stocks
Explore companies with similar themes or neighboring ARK trading activity.